Studies
High-dose ascorbate (HDA) in combination with azacitidine and venetoclax (aza/ven) in newly diagnosed acute myeloid leukemia (AML)
Cancer
Internal Medicine
Leukemia
Adult Subjects
Female Subjects
Male Subjects
This is a randomized, open-label, Phase I clinical study with expansion. It will assess the safety and efficacy of high-dose ascorbate administered concomitantly with azacitidine and venetoclax in newly diagnosed AML.
A prospective randomized, double-blind, placebo-controlled, multi-center phase III study to evaluate the efficacy and safety of mocravimod as an adjunctive and maintenance treatment in adult acute myeloid leukemia (AML) patients undergoing allogeneic h…
Cancer
Internal Medicine
Leukemia
Adult Subjects
This is a multi-center, randomized, double-blinded, placebo controlled trial.